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Abstract
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food
Allergens (NDA) was asked to deliver an opinion on chromium-enriched biomass of Yarrowia lipolytica
as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is the dried and heat-killed
chromium-enriched biomass of Y. lipolytica. This yeast species is widespread in nature, can be found in
the environment and in foods, and was attributed the qualified presumption of safety (QPS) status for
production purposes in 2018, including food and feed products based on biomass of the yeast. The
production process, fermentation in the presence of chromium chloride, includes a heat-killing step of
the yeast, resulting in the absence of viable Y. lipolytica in the NF. The maximum total chromium
content of the NF is 23 lg Cr/g, with the chromium present as Cr(III). The applicant proposed to use
the NF as a food supplement. The target population proposed by the applicant is the general population
from 3 years of age onwards, with maximum proposed use levels of 2 g/day for children from 3 to 9
years of age and 4 g/day thereafter. At the proposed use levels of the NF, the combined intake of
chromium provided by the NF, in addition to a background diet high in chromium, would result in total
chromium intakes well below the tolerable daily intake (TDI) for chromium(III) for all target population
groups. The Panel concludes that the NF, chromium-enriched biomass of Y. lipolytica, is safe under the
proposed conditions of use.
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1. Introduction
1.1. Background and Terms of Reference as provided by the European
Commission
On 22 August 2018, Skotan S.A. submitted a request to the European Commission in accordance
with Article 10 of Regulation (EU) No 2015/22831 to place chromium-enriched biomass from Yarrowia
lipolytica on the Union market as a novel food (NF).
Chromium-enriched biomass from Y. lipolytica is proposed for use in various foods, including food
for special medical purposes, food supplements and total diet replacement foods for weight control.
The target population is the general population, from 3 years of age onwards.
On 18 February 2019, and in accordance with Article 10(3) of Regulation (EU) 2015/2283, the
European Commission asked the European Food Safety Authority (EFSA) to provide a scientific opinion
on chromium-enriched biomass from Y. lipolytica as a NF.
2. Data and methodologies
2.1. Data
The safety assessment of this NF is based on data supplied in the application and information
submitted by the applicant following two EFSA requests for supplementary information.
Administrative and scientific requirements for NF applications referred to in Article 10 of Regulation
(EU) 2015/2283 are listed in the Commission Implementing Regulation (EU) 2017/2469.2
A common and structured format on the presentation of NF applications is described in the EFSA
guidance on the preparation and presentation of NF applications.3 As indicated in this guidance, it is
the duty of the applicant to provide all the available (proprietary, confidential and published) scientific
data, including both data in favour and not in favour to supporting the safety of the proposed NF.
This NF application does not include a request for the protection of proprietary data.
2.2. Methodologies
The assessment follows the methodology set out in the EFSA guidance on NF applications (EFSA
NDA Panel, 2016) and the principles described in the relevant existing guidance documents from the
EFSA Scientific Committee. The legal provisions for the assessment are laid down in Article 11 of
Regulation (EU) 2015/2283 and in Article 7 of Commission Implementing Regulation (EU) 2017/2469.
This assessment concerns only risks that might be associated with consumption of the NF under
the proposed conditions of use and is not an assessment of the efficacy of the NF with regard to any
(claimed) benefit.
3. Assessment
3.1. Introduction
The NF which is the subject of the application is the chromium-enriched biomass of the yeast
Yarrowia lipolytica.
The NF falls under category (ii), i.e. food consisting of, isolated from or produced from
microorganisms, fungi or algae, according to Article 3(2)(a) of Regulation (EU) No 2015/2283.
1 Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods, amending Regulation (EU) No 1169/
2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and
of the Council and Commission Regulation (EC) No 1852/2001 (2013/0435 (COD). OJ L 327, 11.12.2015, p. 1–22.
2 Commission Implementing Regulation (EU) 2017/2469 of 20 December 2017 laying down administrative and scientific
requirements for applications referred to in Article 10 of Regulation (EU) 2015/2283 of the European Parliament and of the
Council on novel foods. OJ L 351, 30.12.2017, pp. 64–71.
3 EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), Turck D, Bresson J-L, Burlingame B, Dean T,
Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle H, Naska A, Neuh€auser-Berthold M, Nowicka G,
Pentieva K, Sanz Y, Siani A, Sj€odin A, Stern M, Tome D, Vinceti M, Willatts P, Engel K-H, Marchelli R, P€oting A, Poulsen M,
Salminen S, Schlatter J, Arcella D, Gelbmann W, de Sesmaisons-Lecarre A, Verhagen H and van Loveren H, 2016. Guidance on
the preparation and presentation of an application for authorisation of a novel food in the context of Regulation (EU) 2015/
2283. EFSA Journal 2016;14(11):4594, 24 pp. https://doi.org/10.2903/j.efsa.2016.4594
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The NF is produced by fermentation using commonly used nutrient sources plus chromium chloride
as a source for chromium. The NF is proposed to be used in food supplements. The target population
is the general population from 3 years of age onwards.
3.2. Identity of the NF
The NF is the chromium-enriched biomass of the yeast Yarrowia lipolytica.
The taxonomic position of Y. lipolytica was first established by Van der Walt and von Arx (1980),
with the following microbiological taxonomy. Kingdom: fungi; sub-kingdom: Dikaryota; division:
Ascomycota; subdivision: Saccharomycotina; class: Saccharomycetes; order: Saccharomycetales;
family: Dipodascaceae; genus: Yarrowia; species: Yarrowia lipolytica.
The species Y. lipolytica can be found in the ‘IndexFungorum’ database4 (record number
ID108643).
In 2018, the EFSA BIOHAZ Panel assessed the yeast, i.e. Y. lipolytica, that is used to produce the
NF, and recommended this yeast for the qualified presumption of safety (QPS) status but only for
production purposes, including food and feed products based on biomass of the yeast (EFSA BIOHAZ
Panel, 2018). The qualification ‘only for production purposes’ requires that there are no viable
Y. lipolytica cells in the final product.
The EFSA NDA Panel has previously favourably assessed the safety of Y. lipolytica yeast biomass as
a novel food (EFSA NDA Panel, 2019).
3.3. Production process
According to the information provided, the NF is produced following Good Manufacturing Practice
(GMP) and Hazard Analysis Critical Control Points (HACCP) principles.
Flow charts of the manufacturing process and detailed information on the culture conditions and
media have been provided (confidential).
The first step of the manufacturing process consists in the preparation of the Y. lipolytica yeast
inoculum. Proliferation of the yeast is continued in tanks of increasing capacity using culture media
consisting of nutrient sources commonly employed in fermentation processes. The culture conditions
(i.e. temperature, aeration, pH, speed of mixing) are continuously monitored.
The main fermentation step is carried out in the presence of chromium chloride, i.e. CrCl3, which is
among the mineral substances authorised to be added to foods (including food supplements).5
After reaching a certain concentration of yeast dry matter, the chromium-enriched yeast is
harvested, i.e. centrifuged, rinsed with water, and centrifuged again in order to remove remnant
culture medium. Thereafter the yeast biomass is dried on a drum drier at a temperature of > 160°C
until a moisture content of less than 5% is achieved. During this step the yeast cells are killed.
As noted in the previous safety assessment of Y. lipolytica (EFSA NDA Panel, 2019), the
Panel reiterates that in order to monitor the efficacy of the heat treatment and to guarantee that there
are no viable Y. lipolytica cells remaining in the dried biomass, testing for the presence of viable yeast
cells has to be carried out immediately after the heat treatment (see also Specifications, Table 4).
The Panel also notes that it has to be ensured that no cross-contamination occurs with viable
Y. lipolytica in the final steps of the manufacturing process (packaging and storage).
The Panel considers that the production process is sufficiently described and does not raise safety
concerns.
3.4. Compositional data
The applicant provided information on chromium content, proximate analysis and microbial counts
for five batches of the NF (Table 1), produced at the intended production scale (i.e. minimum culture
medium of 1,000 L).
Information was provided on the accreditation of the laboratories that conducted the analyses
presented in the application.
4 http://www.indexfungorum.org/names/names.asp
5 Commission Regulation (EC) No 1170/2009 of 30 November 2009 amending Directive 2002/46/EC of the European Parliament
and of Council and Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards the lists of vitamin
and minerals and their forms that can be added to foods, including food supplements, OJ L 314, 1.12.2009, p. 36–42.
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In order to further analyse the nature of the chromium, the NF was subjected to a three-step
sequential extraction (i.e. fractionation) and a simulated in vitro gastrointestinal digestion. The
fractionation steps comprised water extraction and digestion by Driselase and protease, respectively.
About half (50.2%) of the total content of chromium in the analysed sample was found in the water-
soluble part. A further 43.9% of the chromium was polysaccharide-bound and the protein-bound fraction
of chromium amounted to 4.3%. Size-exclusion high-performance liquid chromatography/inductively
coupled plasma-mass spectrometry (HPLC/ICP-MS) was performed with (a) the water extract and (b) an
in vitro gastrointestinal digestate of the NF. The chromatographic analysis confirmed the identity of
chromium as trivalent, i.e. Cr(III). No peak corresponding to Cr(VI) was detected in any of the fractions.
It is noted that food is generally a reducing medium that would likely determine soluble Cr(VI) to
be converted to Cr(III), whereas no oxidation of Cr(III) to Cr(VI) is expected in such a medium (EFSA
CONTAM Panel, 2014), which makes the presence of Cr(VI) in the NF unlikely.
The Panel notes that for some of the batches provided (see Table 1) the microbial counts exceeded
the maximum specified values. According to the information provided, those samples were taken after
the packaging of the NF (i.e. at the end of the manufacturing process). In order to ascertain the
microbiological quality of the NF, the applicant was requested to submit additional analyses for five
batches of the NF to be sampled immediately after the heat inactivation step. The results of the
additional analyses as submitted by the applicant following the EFSA request are given in Table 2.
The Panel considers that the information provided on the composition of the NF is sufficient and
does not raise safety concerns.
Table 1: Batch-to-batch analysis of the NF (produced at production scale)
Parameter (unit)
Batch number
Cr01-19 Cr02-19 Cr03-19 Cr04-19 Cr05-19
Chromium (lg/g) 22.4 20.6 22.8 19.3 21.1
Protein (%) 43.6 45.1 46.1 47.4 44.7
Dietary fibre (%) 30.7 24.7 29.5 25.8 30.2
Sugars (%) < 0.2 < 0.2 1.0 1.6 0.6
Fat (%) 9.5 9.0 9.3 8.5 10.7
Dry matter (%) 93.5 93.1 95.9 96.4 95.4
Water (%) 6.5 6.9 4.1 3.6 4.6
Ash (%) 9.0 9.1 10.0 10.4 9.8
Contaminants
Cadmium (mg/kg) 0.022 0.023 0.028 0.033 0.031
Mercury (mg/kg) 0.012 0.029 0.024 0.027 0.027
Lead (mg/kg) 0.017 0.019 0.055 0.039 0.018
Microbials
TAMC (CFU/g) 1.2 9 104 < 10 1.7 9 105 1.2 9 102 1.3 9 104
TYMC (CFU/g) 8 9 103 < 10 7.3 9 104 1 9 102 1.4 9 104
Coliforms (in 1 g) < 10 < 10 < 10 < 10 < 10
Salmonella spp. (in 25 g) Not detected Not detected Not detected Not detected Not detected
TAMC: total aerobic microbial count, TYMC: total yeast and mould count, CFU: colony forming units.
Table 2: Additional microbiological analyses for five batches of the NF
Parameter (unit)
Batch number
Cr06-19 Cr07-19 Cr08-19 Cr09-19 Cr10-19
TAMC (CFU/g) < 10 1.1 9 102 8.0 9 102 < 10 5.2 9 102
TYMC (CFU/g) < 10 < 10 < 10 < 10 < 10
Coliforms (CFU/g) < 10 < 10 < 10 < 10 < 10
Salmonella spp. (in 25 g) Not detected Not detected Not detected Not detected Not detected
TAMC: total aerobic microbial count, TYMC: total yeast and mould count, CFU: colony forming units.
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3.4.1. Stability
In order to demonstrate the stability of the NF, the applicant submitted results of stability testing
performed for 12 months at ambient conditions (20°C and 40–60% relative humidity (RH)) (Table 2).
Four batches of the NF were analysed. The parameters investigated were the content of total
chromium, water, protein, fat, total aerobic microbial count (TAMC), total yeast and mould count
(TYMC), Coliforms and Salmonella. Salmonella and Coliforms were not detected (i.e. absent in 25 g
and 1 g, respectively) in any sample over the testing period. Protein and fat contents decreased
slightly over time. Results for total chromium content, TAMC, TYMC and water content are shown in
Table 3.
In addition, the applicant performed stability tests with one batch (Nr. CrAJ46) of the NF at
standard (30°C and at 65% RH) and at accelerated storage conditions (40°C and at 75% RH) for
6 months. The batch of the NF was analysed for its content of chromium, water, protein, B-group
vitamins and for microbial counts. No relevant changes were observed in any parameter over the
testing period at standard and accelerated conditions, respectively.
Given the absence of relevant changes in the composition of the NF under ambient conditions for
up to 12 months and accelerated storage conditions for up to 6 months, the applicant proposed a
shelf-life of 12 months for the NF.
The Panel considers that the applicant provided sufficient information with respect to the stability of
the NF up to 12 months under ambient conditions.
3.5. Specifications
The specifications of the NF are indicated in Table 4.
Table 3: Stability testing at ambient conditions for chromium (lg/g), TAMC (CFU/g), TYMC (CFU/g)
and water content (in %)
Batch # Param
Time (in months)
1 2 3 4 5 6 7 8 9 10 11 12
CrAJ47 Chrom. 18.7 18.7 18.6 18.5 18.6 18.4 18.4 18.4 18.4 18.3 18.3 18.2
TAMC 50 54 60 54 46 33 28 20 17 10 < 10 < 10
TYMC 20 25 22 18 15 12 8 < 10 < 10 < 10 < 10 < 10
Water 4.1 4.1 4.4 4.4 4.2 4.3 4.1 3.8 3.7 3.5 3.6 3.4
CrAK48 Chrom. 19.8 19.8 19.8 19.7 19.7 19.7 19.6 19.6 19.6 19.5 19.4 19.4
TAMC 10 25 28 15 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
TYMC 10 10 < 10 < 10 < 10 < < 10 < 10 < 10 < 10 < 10 < 10 < 10
Water 2.8 2.8 2.9 2.1 2.7 2.4 2.2 2.5 2.2 2.0 1.8 1.7
CrAK49 Chrom. 20.2 20.1 20.2 20.1 20.1 20.0 20.0 19.9 19.9 19.9 19.9 19.8
TAMC 100 110 82 70 60 44 33 18 < 10 < 10 < 10 < 10
TYMC 30 20 18 15 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
Water 4.6 4.4 4.7 4.8 4.6 4.3 4.1 3.9 4.0 3.8 3.7 3.6
CrAK50 Chrom. 17.9 17.9 17.8 17.7 17.6 17.5 17.5 17.4 17.3 17.2 17.1 17.1
TAMC 160 120 90 85 76 60 43 20 12 < 10 < 10 < 10
TYMC 45 40 30 15 10 < 10 < 10 < 10 < 10 < 10 < 10 < 10
Water 3.2 3.3 3.6 3.4 3.3 3.1 3.0 3.0 2.8 2.7 2.8 2.6
TAMC: total aerobic microbial count, TYMC: total yeast and mould count, CFU: colony forming units, Chrom: chromium. The
numbers of the microbial counts have to be multiplied by 10 in order to account for the dilution factor.
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The Panel considers that the information provided on the specifications of the NF is sufficient and
does not raise safety concerns.
3.6. History of use of the NF and/or of its source
There is no history of consumption of the NF.
The yeast, i.e. Y. lipolytica, which is used to produce the NF, is widespread in nature and can
naturally be found in foods high in fat and protein (e.g. cured meat, dairy products, various types of
cheese).
In 2019, the EFSA NDA Panel favourably assessed the safety of Y. lipolytica yeast biomass as a
novel food (EFSA NDA Panel, 2019).
Also in 2019, Y. lipolytica heat-killed yeast biomass was authorised for the placing on the market in/as
food supplements, excluding food supplements for infants and young children (Commission
Implementing Regulation (EU) 2019/7666).
3.7. Proposed uses and use levels and anticipated intake
3.7.1. Target population
The target population for the NF is the general population from 3 years of age onwards.
Table 4: Specifications of the NF
Parameter Amount Method
Total chromium 18–23 lg/g PN-EN ISO 17294-2:2006
Chromium (VI)(*) < 10 lg/kg (i.e. limit of
detection)
HPLC/ICP-MS
Protein 40–50 g/100 g PN-A-79005-7:1997 or PN-EN ISO 8968-1:2014-03
Dietary fibre 24–32 g/100 g AOAC 985.29 or PN-A-79011-15:1998
Sugars < 2.0 g/100 g PN-A-74252:1998
Fat 6–12 g/100 g AOAC 922.06 or PN-ISO 1444:2000
Ash ≤ 15% PN-ISO 928:1999
Water ≤ 5% PN-EN ISO 665:2004
Dry matter ≥ 95% PN-EN ISO 665:2004
Heavy metals
Lead ≤ 3.0 mg/kg PN-EN ISO 17294-2:2006
Cadmium ≤ 1.0 mg/kg PN-EN ISO 17294-2:2006
Mercury ≤ 0.1 mg/kg PN-EN 13804:2013-06 + ASA mercury analyser or PN-EN
13806:2003
Microbiological
TAMC ≤ 5 9 103 CFU/g PN-EN ISO 4833:2004 + AP1:2005
TYMC ≤ 102 CFU/g PN-ISO 7954:1999
Viable Yarrowia
lipolytica cells(1)
< 10 CFU/g (i.e. limit of
detection)
PN-ISO 7954:1999
Coliforms ≤ 10 CFU/g PN-ISO 4832:2007
Salmonella spp. Absent in 25 g PN-EN ISO 6579:2003
HPLC/ICP-MS: high-performance liquid chromatography/inductively coupled plasma-mass spectrometry; TAMC: total aerobic
microbial count; TYMC: total yeast and mould count; CFU: colony forming units.
(1): To be tested immediately after the heat-treatment step. Measures have to be in place to prevent cross-contamination with
viable Yarrowia lipolytica cells during packaging and/or storage of the NF.
(*): Even though the presence of chromium(VI) in the NF is unlikely (see Section 3.4), the Panel considers that this parameter
should be added to the specifications of the NF.
6 Commission Implementing Regulation (EU) 2019/760 of 13 May 2019 authorising the placing on the market of Yarrowia
lipolytica yeast biomass as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and
amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance.) OJ L 125, 14.5.2019, p. 13–15.
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3.7.2. Proposed uses and use levels
Following a request for clarification on the proposed uses, the applicant stated that the NF is
proposed to be used in food supplements only (in the form of soft or hard capsules, tablets or loose
powder).
The maximum doses of the NF proposed by the applicant are 2 g per day for children from 3 to
9 years of age and 4 g/day thereafter (i.e. adolescents and adults).
3.7.3. Combined intake of chromium from the NF and other sources
In 2014, chronic dietary exposure to Cr(III) was estimated by the EFSA CONTAM Panel in their risk
assessment of chromium in food and drinking water (EFSA CONTAM Panel, 2014). Mean chronic
dietary exposure values, across the different dietary surveys and age classes, ranged from 0.6 lg/kg
body weight (bw) per day (minimum lower bound)7 to 5.9 lg/kg bw per day (maximum upper
bound).8 The high dietary exposure (i.e. 95th percentile) ranged from 1.1 lg/kg bw per day (minimum
lower bound) to 7.9 lg/kg bw per day (maximum upper bound) (excluding infants and toddlers) (EFSA
CONTAM Panel, 2014).
Considering a maximum chromium concentration in the NF of 23 lg Cr/g (upper level as set in the
specifications), the high (i.e. P95) dietary chromium intakes (as estimated in 2014) were used for the
intake scenario for the various target population groups (Table 5).
The combined intake of chromium from the NF taking into account a background diet high in
chromium results in total chromium intakes of 9.9, 6.9 and 3.9 lg Cr/kg bw per day for children from
3 to 9 years, adolescents and adults, respectively.
3.8. Absorption, distribution, metabolism and excretion (ADME)
No ADME data have been provided for the NF.
3.9. Nutritional information
In its opinion on the safety of Y. lipolytica yeast biomass, the Panel concluded that, taking into
account the composition of the NF and the proposed conditions of use, the consumption of the NF is
not nutritionally disadvantageous (EFSA NDA Panel, 2019). This conclusion was based on the
nutritional analysis of the NF (which comprised information on the protein content, amino acid
composition, carbohydrates, fibre, fatty acids, vitamins and minerals in the NF) and the proposed
conditions of use (i.e. 3 g/day for children from 3 to 9 years of age and up to 6 g/day thereafter).
The Y. lipolytica biomass which is subject of the current safety assessment is enriched with
chromium, with up to 23 lg chromium (III) per g (i.e. upper level in the specifications). The proposed
Table 5: Intake scenario for chromium, based on high (i.e. P95) dietary Cr intakes and the use of
the NF as proposed by the applicant considering a maximum chromium concentration of
23 lg Cr/g in the NF
Population
Age
(years)
Proposed
use of the
NF (g/day)
Cr from
the NF
(lg/day)
Cr from
the NF
(lg/kg bw
per day)(1)
P95 dietary
Cr-intake
(lg/kg bw
per day)(2)
Combined
Cr-intake
(lg/kg bw
per day)
TDI(3) for
Cr(III)
(lg/kg bw
per day)
Comb.
intake in
% of the
TDI
Children 3–9 2 46 2.0 7.9 9.9 300 3.3%
Adolescents 10–17 4 92 2.1 4.8 6.9 2.3%
Adults ≥ 18 4 92 1.3 2.6 3.9 1.3%
NF: novel food; bw: body weight.
(1): Derived by dividing the amount of chromium provided by the NF with the default body weights proposed by the Scientific
Committee (EFSA Scientific Committee, 2012) (children of 3–9 years: 23.1 kg; adolescents of 10–14 years: 43.4 kg; adults:
70 kg).
(2): Dietary exposure assessment performed by the EFSA CONTAM Panel (EFSA CONTAM Panel, 2014).
(3): TDI (Tolerable Daily Intake) (EFSA CONTAM Panel, 2014); see also Section 3.10.
7 Lower bound: for results reported to be below the limit of quantification (LoQ) and limit of detection (LoD), the value was
imputed as zero.
8 Upper bound: for results reported to be below the LoD, the value was imputed as LoD, and for those below the LoQ, the value
was imputed as the value reported for the LoQ.
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intake (i.e. up to 2 g/day for children from 3 to 9 years of age and up to 4 g/day thereafter) would
result in a chromium (III) consumption of 46 lg/day for children from 3 to 9 years and 92 lg/day
thereafter.
In its Scientific Opinion on dietary reference values (DRVs) for chromium, the NDA Panel concluded
that the essential function of chromium (as Cr(III)) in metabolism has not been substantiated and no
average requirement (AR) and population reference intake (PRI) for chromium can be defined. The
Panel also concluded that there was no evidence of beneficial effects associated with chromium intake
in healthy subjects and, therefore, the setting of an adequate intake (AI) for chromium was also not
appropriate (EFSA NDA Panel, 2014).
The Panel considers that taking into account the composition of the NF and the proposed
conditions of use the consumption of the NF is not nutritionally disadvantageous.
3.10. Toxicological information
The applicant did not submit any relevant toxicological studies performed with the NF.
No human studies with the NF, which assessed safety-related parameters, were provided.
The Panel considers that given the QPS status for production purposes of Y. lipolytica (see
Section 3.2), the compositional data of the NF and the fact that the production process of the NF does
not raise safety concerns, no toxicological studies are needed for the safety assessment of the NF.
In 2014, the EFSA Panel on Contaminants in the Food Chain (EFSA CONTAM Panel) derived a
tolerable daily intake (TDI) of 300 lg Cr(III)/kg bw per day based on the NOAEL of a 2-year oral
toxicity study in rats (where no adverse effects were observed even at the highest dose tested) and by
applying an uncertainty factor of 1,000 (EFSA CONTAM Panel, 2014). This uncertainty factor of 1,000
contained an extra factor of 10 in order to account for the absence of adequate data on reproductive
and developmental toxicity.
The Panel notes that at the proposed use levels of the NF, the combined intake of chromium
provided by the NF in addition to a background diet high in chromium would result in total chromium
intakes well below the TDI for all target population groups (i.e. 3.3%, 2.3% and 1.3% of the TDI for
children from 3 to 9 years, adolescents and adults, respectively).
3.11. Allergenicity
In its previous opinion on Y. lipolytica biomass, the Panel considered that the risk of allergic
reactions to the biomass of Y. lipolytica is low (EFSA NDA Panel, 2019).
The Panel considers that the previous conclusion on the allergenicity of Y. lipolytica biomass also
applies to the NF under assessment, i.e. chromium-enriched Y. lipolytica biomass.
4. Discussion
The NF is the chromium-enriched biomass of the yeast Y. lipolytica, which is produced by
fermentation in the presence of chromium chloride.
The NF is proposed by the applicant to be used in food supplements for the general population from
3 years of age onwards. The maximum use levels of the NF proposed by the applicant are 2 g/day for
children from 3 to 9 years of age and 4 g per day thereafter (i.e. adolescents and adults), with a
maximum chromium concentration in the NF of 23 lg Cr/g and with the chromium present as Cr(III).
The Panel notes that the essentiality of chromium (as Cr(III)) in humans has not been
substantiated and that the setting of a DRV for chromium was not appropriate (EFSA NDA Panel,
2014).
Y. lipolytica has been attributed QPS status for production purposes, including food and feed
products based on biomass of the yeast. The qualification ‘for production purposes’ requires that there
are no viable Y. lipolytica cells in the final product.
In 2019, the Panel has favourably assessed the safety of Y. lipolytica biomass at levels up to 3 g/day
for children from 3 to 9 years of age and up to 6 g/day thereafter.
No relevant toxicological information was provided for the NF. The Panel considers that given the
QPS status of the yeast, the compositional data of the NF and the fact that the production process of
the NF does not raise safety concerns, no toxicological studies are needed for the safety assessment of
the NF.
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The Panel notes that at the proposed use levels of the NF, the combined intake of chromium
provided by the NF in addition to a background diet high in chromium would result in total chromium
intakes well below the TDI for chromium(III) for all target population groups.
5. Conclusions
The Panel concludes that the NF, chromium-enriched biomass of Y. lipolytica, is safe under the
proposed conditions of use. The target population is the general population above 3 years of age.
Steps taken by EFSA
1) Letter from the European Commission to the European Food Safety Authority with the request
for a scientific opinion on the safety of chromium-enriched biomass from Y. lipolytica as a
novel food. Ref. Nr. Ares(2019)988250, dated 18 February 2019.
2) On 18 February 2019, a valid application on chromium-enriched biomass from Y. lipolytica,
which was submitted by Skotan S.A., was made available to EFSA by the European
Commission through the Commission e-submission portal (NF 2018/0556) and the scientific
evaluation procedure was initiated.
3) On 3 May 2019, EFSA requested the applicant to provide additional information to accompany
the application and the scientific evaluation was suspended.
4) On 30 August 2019, additional information was provided by the applicant and the scientific
evaluation was restarted.
5) On 18 October 2019, EFSA requested the applicant to provide additional information to
accompany the application and the scientific evaluation was suspended.
6) On 12 December 2019, additional information was provided by the applicant and the scientific
evaluation was restarted.
7) During its meeting on 23 January 2020, the NDA Panel, having evaluated the data, adopted a
scientific opinion on the safety of chromium-enriched biomass from Y. lipolytica as a NF
pursuant to Regulation (EU) 2015/2283.
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Abbreviations
ADME absorption, distribution, metabolism and excretion
AI adequate intake
AR average requirement
BIOHAZ EFSA Panel on Biological Hazards
bw body weight
CFU colony forming units
Chrom chromium
CONTAM EFSA Panel on Contaminants in the Food Chain
DRV dietary reference value
GMP Good Manufacturing Practice
HACCP Hazard Analysis Critical Control Points
HPLC high-performance liquid chromatography
ICP-MS inductively coupled plasma-mass spectrometry
LoD limit of detection
LoQ limit of quantification
NDA Nutrition, Novel Foods and Food Allergens
NF novel food
NOAEL no observed adverse effect level
OECD Organisation for Economic Co-operation and Development
PRI population reference intake
QPS qualified presumption of safety
RH relative humidity
TAMC total aerobic microbial count
TDI tolerable daily intake
TYMC total yeast and mould count
UL tolerable upper intake level
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